Dingdang Health Technology Group Ltd. (HK:9886)
:9886
Want to see HK:9886 full AI Analyst Report?
9886 Stock Chart & Stats
HK$1.08
-HK$0.02(-3.23%)
At close: 4:00 PM EST
HK$1.08
-HK$0.02(-3.23%)
Day’s Range― - ―
52-Week RangeHK$0.31 - HK$1.37
Previous CloseN/A
Volume431.00K
Average Volume (3M)4.91M
Market Cap
HK$1.38B
Enterprise ValueHK$851.21M
Total Cash (Recent Filing)HK$1.36B
Total Debt (Recent Filing)HK$263.13M
Price to Earnings (P/E)―
Beta1.95
Next Earnings
Aug 21, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding1,319,472,900
10 Day Avg. Volume8,114,443
30 Day Avg. Volume4,906,414
Financial Highlights & Ratios
PEG Ratio0.30
Price to Book (P/B)0.75
Price to Sales (P/S)0.26
P/FCF Ratio10.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.07
Revenue Forecast (FY)HK$6.85B
Bulls Say, Bears Say
Bulls Say
Revenue & Margin RecoveryA sharp revenue rebound and improving gross margin indicate the O2O pharmacy model is regaining scale and improving unit economics. Sustained top-line growth with margin expansion supports a credible path to profitability, stronger cash conversion and improved competitive positioning over the medium term.
Positive Cash GenerationThe swing to positive operating and free cash flow provides recurring liquidity to fund operations, invest in pharmacy network and delivery, and reduce reliance on external financing. Durable cash generation would materially strengthen financial flexibility and reduce execution risk versus loss-making peers.
Manageable LeverageLow leverage and restored positive equity after prior stress enhance the company's capacity to invest for growth and absorb shocks. A healthier balance sheet supports capital allocation for expansion of fulfillment capabilities without immediate refinancing pressure or heavy covenant constraints.
Bears Say
Residual UnprofitabilityDespite progress, recurring net losses and negative ROE indicate the company has not achieved sustainable profitability. Continued subpar bottom-line performance leaves earnings exposed to cost inflation, competitive pricing pressure, and delays the firm’s ability to self-fund growth without dilutive or debt financing.
Cash-Flow VolatilityHistoric swings in cash flow suggest the 2025 cash turnaround may not be fully durable. If improvements are driven by timing or one-off working-capital shifts rather than structural margin gains, cash generation could revert, constraining reinvestment and raising liquidity or refinancing risk over the next several quarters.
Historical Balance-Sheet StressA prior episode of negative equity and heavy leverage signals past execution and financing weaknesses. Even with recent repair, the history raises the bar for management to demonstrate consistent execution; renewed underperformance could quickly reintroduce solvency or access-to-capital challenges.
Dingdang Health Technology Group Ltd. News
9886 FAQ
What was Dingdang Health Technology Group Ltd.’s price range in the past 12 months?
Dingdang Health Technology Group Ltd. lowest stock price was HK$0.30 and its highest was HK$1.37 in the past 12 months.
What is Dingdang Health Technology Group Ltd.’s market cap?
Dingdang Health Technology Group Ltd.’s market cap is HK$1.38B.
When is Dingdang Health Technology Group Ltd.’s upcoming earnings report date?
Dingdang Health Technology Group Ltd.’s upcoming earnings report date is Aug 21, 2026 which is in 110 days.
How were Dingdang Health Technology Group Ltd.’s earnings last quarter?
Dingdang Health Technology Group Ltd. released its earnings results on Mar 20, 2026. The company reported HK$0.002 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.002.
Is Dingdang Health Technology Group Ltd. overvalued?
According to Wall Street analysts Dingdang Health Technology Group Ltd.’s price is currently Overvalued.
Does Dingdang Health Technology Group Ltd. pay dividends?
Dingdang Health Technology Group Ltd. does not currently pay dividends.
What is Dingdang Health Technology Group Ltd.’s EPS estimate?
Dingdang Health Technology Group Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dingdang Health Technology Group Ltd. have?
Dingdang Health Technology Group Ltd. has 1,319,472,900 shares outstanding.
What happened to Dingdang Health Technology Group Ltd.’s price movement after its last earnings report?
Dingdang Health Technology Group Ltd. reported an EPS of HK$0.002 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.205%.
Which hedge fund is a major shareholder of Dingdang Health Technology Group Ltd.?
Currently, no hedge funds are holding shares in HK:9886
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dingdang Health Technology Group Ltd. Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
80.00%
12-Months-Change
Fundamentals
Return on Equity
-11.93%
Trailing 12-Months
Asset Growth
12.67%
Trailing 12-Months
Company Description
Dingdang Health Technology Group Ltd.
Dingdang Health Technology Group Ltd. operates as a service provider in the digital retail pharmacy industry in the People's Republic of China. The company offers pharmaceutical retail and medical consultation services. Dingdang Health Technology Group Ltd. was incorporated in 2014 and is headquartered in Beijing, the People's Republic of China.
Technical Analysis
Human Health Holdings Ltd.
―
Yonghe Medical Group Co., Ltd.
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hospital Corporation of China Ltd
―
Town Health International Medical Group Ltd.
―
Options Prices
Currently, No data available
---